Cardiolipin

Cardiolipin is a structurally distinctive dimeric phospholipid — composed of two phosphatidic acid moieties linked by a glycerol backbone — found almost exclusively in the inner mitochondrial membrane (IMM). Its unique four-acyl-chain structure and strong anionic charge at physiological pH make it a critical architectural and functional component of the IMM, where it constitutes approximately 20% of total lipid content.

Why it matters in peptide research

Cardiolipin's importance cannot be overstated: it is required for the full catalytic activity of all five complexes of the oxidative phosphorylation machinery. By stabilizing the supramolecular assemblies of respiratory chain complexes — known as respirasomes or supercomplexes — cardiolipin dramatically increases electron transfer efficiency and reduces reactive oxygen species (ROS) leak. Loss of cardiolipin content or its peroxidation by ROS creates a vicious cycle: impaired ETC efficiency generates more ROS, which further damages cardiolipin, propagating mitochondrial dysfunction.

Cardiolipin also plays a central role in intrinsic apoptosis. Under conditions of severe oxidative stress, cytochrome c — normally tethered to the IMM by electrostatic interactions with cardiolipin — is released upon cardiolipin peroxidation, initiating caspase activation and cell death. This positions cardiolipin oxidation as an early upstream event in stress-induced apoptosis, making it a compelling target for cytoprotective interventions.

In aging and disease states including heart failure, ischemia-reperfusion injury, Barth syndrome, and neurodegeneration, cardiolipin content and acyl-chain composition are consistently altered. Restoring cardiolipin integrity is therefore a mechanistic rationale for therapeutic approaches targeting mitochondrial dysfunction at its structural root.

Peptides that act on this

• SS-31 (Elamipretide, Bendavia) — a tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH2) that selectively concentrates in the IMM by binding cardiolipin; SS-31 reduces cardiolipin peroxidation, stabilizes cristae architecture, and restores respiratory supercomplex assembly; in clinical trials for Barth syndrome and heart failure.
• MOTS-c — mitochondria-derived peptide that may influence IMM homeostasis indirectly through AMPK-mediated metabolic rebalancing.

Common misconceptions

Cardiolipin is sometimes treated as a passive structural lipid. In reality, it is a dynamic signaling molecule: cardiolipin externalized to the outer mitochondrial membrane acts as an "eat me" signal for mitophagy — the selective autophagy of damaged mitochondria. This role in mitochondrial quality control means that cardiolipin metabolism is intimately connected to mitophagy efficiency, which declines with age and in metabolic disease.